Skip to main content

Table 2 Multivariate analysis of factors associated with S2/3 graft steatosis

From: High prevalence of de novo metabolic dysfunction-associated fatty liver disease after liver transplantation and the role of controlled attenuation parameter

Parameter

HR (95% CI)

P value

BMI at CAP measurement

Diabetes mellitus

Hypertension

HDL-cholesterol

LDL-cholesterol

Cryptogenic cirrhosis

1.34 (1.20–1.49)

2.01 (1.09–3.71)

2.03 (1.04–3.94)

0.25 (0.10–0.58)

1.50 (1.05–2.16)

4.85 (1.45–16.3)

< 0.001

0.026

0.037

0.001

0.027

0.011